This company listing is no longer active
DBV Technologies Crecimiento futuro
Future controles de criterios 2/6
Información clave
36.7%
Tasa de crecimiento de los beneficios
-5.5%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Biotechs | 24.5% |
Tasa de crecimiento de los ingresos | 66.3% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2024 | 3 | -108 | -143 | -125 | 2 |
12/31/2023 | 5 | -92 | -110 | -75 | 2 |
12/31/2022 | 7 | -81 | -100 | -66 | 1 |
6/30/2022 | 8 | -77 | -54 | -53 | N/A |
3/31/2022 | 5 | -85 | -74 | -74 | N/A |
12/31/2021 | 6 | -98 | -109 | -108 | N/A |
9/30/2021 | 2 | -124 | -124 | -123 | N/A |
6/30/2021 | 4 | -131 | -144 | -142 | N/A |
3/31/2021 | 9 | -148 | -154 | -152 | N/A |
12/31/2020 | 11 | -160 | -168 | -166 | N/A |
9/30/2020 | 17 | -161 | -157 | -153 | N/A |
6/30/2020 | 16 | -171 | -156 | -151 | N/A |
3/31/2020 | 16 | -169 | -161 | -156 | N/A |
12/31/2019 | 15 | -172 | -154 | -148 | N/A |
9/30/2019 | 12 | -176 | -156 | -151 | N/A |
6/30/2019 | 13 | -198 | -176 | -169 | N/A |
3/31/2019 | 13 | -191 | -166 | -160 | N/A |
12/31/2018 | 13 | -190 | -162 | -156 | N/A |
9/30/2018 | 11 | -178 | -164 | -157 | N/A |
6/30/2018 | 11 | -172 | -149 | -145 | N/A |
3/31/2018 | 11 | -182 | -154 | -147 | N/A |
12/31/2017 | 12 | -177 | -146 | -137 | N/A |
9/30/2017 | 11 | -169 | -126 | -118 | N/A |
6/30/2017 | 11 | -157 | -104 | -97 | N/A |
3/31/2017 | 9 | -135 | -85 | -77 | N/A |
12/31/2016 | 8 | -121 | -72 | -63 | N/A |
9/30/2016 | 8 | -109 | -68 | -58 | N/A |
6/30/2016 | 8 | -88 | -60 | -49 | N/A |
3/31/2016 | 8 | -72 | N/A | -41 | N/A |
12/31/2015 | 7 | -49 | N/A | -29 | N/A |
9/30/2015 | 6 | -40 | N/A | -28 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: DBVT.F is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: DBVT.F is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: DBVT.F is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: DBVT.F's revenue (66.3% per year) is forecast to grow faster than the US market (7.8% per year).
Ingresos de alto crecimiento: DBVT.F's revenue (66.3% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if DBVT.F's Return on Equity is forecast to be high in 3 years time